R Markdown
##This is now both phases
##So far we have: MSC Band 2 for Long VEP, SAND Results, CGI-I
Results, ABS, RBS-R, ADAMS, Caregiver VAS, Sensory Profile
For now - used last observation carried forward for missing
data
##IGF1 ##This is Baseline levels only to look for carryover of
IGF1
IGF1
| A |
baseline_phase_1_arm_1 |
A |
135.6667 |
114.19574 |
15 |
| A |
baseline_phase_2_arm_1 |
B |
143.0667 |
100.32196 |
15 |
| B |
baseline_phase_1_arm_1 |
B |
119.4286 |
63.57759 |
15 |
| B |
baseline_phase_2_arm_1 |
A |
123.4167 |
66.92527 |
14 |

##Based on this, it doesn’t look like overall there was carryover of
IGF1 ##mean values at baseline 1 and baseline 2 are similar - i think we
should z score this but not sure the population levels that we used
before
##IGF1 model ##1) look for carryover
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: IGF1 ~ EVENT + DRUG + DRUG * EVENT + GROUP * DRUG + (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: 1207.2
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -1.98331 -0.49626 -0.07543 0.40580 2.58199
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 5965 77.24
## Residual 2082 45.63
## Number of obs: 113, groups: record_id, 29
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 133.936 22.467 36.373 5.962 7.53e-07 ***
## EVENTWeek_12 -1.139 12.275 80.290 -0.093 0.926
## DRUGB -6.043 14.597 80.150 -0.414 0.680
## GROUPB -1.294 31.228 31.848 -0.041 0.967
## EVENTWeek_12:DRUGB 97.839 17.251 80.244 5.671 2.16e-07 ***
## DRUGB:GROUPB 9.086 17.270 80.247 0.526 0.600
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB GROUPB EVENTW_12:
## EVENTWek_12 -0.273
## DRUGB -0.326 0.420
## GROUPB -0.661 -0.019 0.144
## EVENTW_12:D 0.194 -0.712 -0.578 0.014
## DRUGB:GROUP 0.169 0.035 -0.542 -0.281 -0.036
##here what we care about is group*drug interaction which is looking
for carryover ## term not significant, so just on IGF1 it seems no
carryover which is good
##MSC Bands 1-2, P60-N75 Difference
| Baseline |
A |
0.3869310 |
0.1595297 |
29 |
| Week_12 |
A |
0.3899655 |
0.1751706 |
29 |
| Baseline |
B |
0.3598929 |
0.1495443 |
30 |
| Week_12 |
B |
0.3799200 |
0.1605194 |
29 |
| Baseline |
A |
0.3574828 |
0.1866616 |
29 |
| Week_12 |
A |
0.3755517 |
0.2064568 |
29 |
| Baseline |
B |
0.3283571 |
0.1882139 |
30 |
| Week_12 |
B |
0.3754400 |
0.1589497 |
29 |
| Baseline |
A |
0.2172414 |
0.1538758 |
29 |
| Week_12 |
A |
0.1824138 |
0.1555469 |
29 |
| Baseline |
B |
0.1956429 |
0.1340266 |
30 |
| Week_12 |
B |
0.2046400 |
0.1275967 |
29 |
| Baseline |
A |
0.1196552 |
0.0504446 |
29 |
| Week_12 |
A |
0.1465517 |
0.0765980 |
29 |
| Baseline |
B |
0.1283214 |
0.0680626 |
30 |
| Week_12 |
B |
0.1464800 |
0.0723776 |
29 |
| Baseline |
A |
4.157586 |
3.487043 |
29 |
| Week_12 |
A |
4.317931 |
4.075812 |
29 |
| Baseline |
B |
3.590714 |
2.722051 |
30 |
| Week_12 |
B |
4.924000 |
4.659851 |
29 |
Plots for VEP
iASD and PMS separate


Modeling for VEP
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: vep_long_msc_band_2 ~ EVENT + DRUG + DRUG * EVENT + (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: -100.9
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -1.72815 -0.49735 -0.07145 0.64216 2.08483
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 0.02330 0.1527
## Residual 0.01129 0.1062
## Number of obs: 111, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 0.36233 0.03422 49.13318 10.587 2.83e-14 ***
## EVENTWeek_12 0.01807 0.02790 78.12721 0.648 0.519
## DRUGB -0.03934 0.02846 78.90107 -1.382 0.171
## EVENTWeek_12:DRUGB 0.01908 0.04058 78.33697 0.470 0.640
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB
## EVENTWek_12 -0.408
## DRUGB -0.406 0.490
## EVENTW_12:D 0.280 -0.687 -0.685
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: vep_long_msc_band_2 ~ EVENT + DRUG + DRUG * EVENT + GROUP + (1 |
## record_id)
## Data: ghin_person
##
## REML criterion at convergence: -97.1
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -1.72947 -0.49515 -0.05799 0.64552 2.06891
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 0.02419 0.1555
## Residual 0.01129 0.1062
## Number of obs: 111, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 0.35428 0.04584 36.94267 7.729 3.13e-09 ***
## EVENTWeek_12 0.01807 0.02790 78.14316 0.648 0.519
## DRUGB -0.03958 0.02846 78.83357 -1.391 0.168
## GROUPB 0.01628 0.06042 28.10272 0.269 0.790
## EVENTWeek_12:DRUGB 0.01906 0.04058 78.34507 0.470 0.640
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB GROUPB
## EVENTWek_12 -0.304
## DRUGB -0.288 0.490
## GROUPB -0.655 0.000 -0.022
## EVENTW_12:D 0.207 -0.687 -0.685 0.003
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: vep_long_msc_band_2 ~ DRUG + EVENT + DRUG * EVENT + diag_dx___1 +
## (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: -97.1
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -1.73979 -0.49360 -0.06645 0.63904 2.07831
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 0.02425 0.1557
## Residual 0.01129 0.1062
## Number of obs: 111, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 0.360955 0.045880 36.899960 7.867 2.09e-09 ***
## DRUGB -0.039448 0.028466 78.811279 -1.386 0.170
## EVENTWeek_12 0.018069 0.027900 78.121652 0.648 0.519
## diag_dx___1PMS 0.002838 0.060488 28.081288 0.047 0.963
## DRUGB:EVENTWeek_12 0.019029 0.040583 78.323282 0.469 0.640
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) DRUGB EVENTW d____1
## DRUGB -0.288
## EVENTWek_12 -0.304 0.490
## dg_d___1PMS -0.655 -0.022 0.000
## DRUGB:EVENT 0.207 -0.685 -0.687 0.003
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: PNAMP ~ EVENT + DRUG + DRUG * EVENT + GROUP * DRUG + (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: 545.7
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -2.9786 -0.4760 -0.1578 0.3201 4.1551
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 8.836 2.973
## Residual 5.268 2.295
## Number of obs: 111, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 3.9048 0.9249 43.1214 4.222 0.000123 ***
## EVENTWeek_12 0.1603 0.6028 77.6271 0.266 0.790934
## DRUGB -0.9392 0.7691 79.1378 -1.221 0.225631
## GROUPB 0.5701 1.2456 35.9552 0.458 0.649949
## EVENTWeek_12:DRUGB 0.9524 0.8767 77.8712 1.086 0.280662
## DRUGB:GROUPB 0.5426 0.8947 79.4856 0.606 0.545964
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB GROUPB EVENTW_12:
## EVENTWek_12 -0.326
## DRUGB -0.375 0.392
## GROUPB -0.664 0.000 0.184
## EVENTW_12:D 0.224 -0.688 -0.555 -0.001
## DRUGB:GROUP 0.212 0.000 -0.601 -0.336 0.011
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: PNAMP ~ EVENT + DRUG + DRUG * EVENT + (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: 550.4
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -3.0187 -0.4648 -0.1220 0.3472 4.2583
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 8.674 2.945
## Residual 5.225 2.286
## Number of obs: 111, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 4.1942 0.6867 53.9258 6.107 1.15e-07 ***
## EVENTWeek_12 0.1603 0.6003 78.6101 0.267 0.790
## DRUGB -0.6483 0.6119 79.5006 -1.059 0.293
## EVENTWeek_12:DRUGB 0.9449 0.8730 78.8585 1.082 0.282
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB
## EVENTWek_12 -0.437
## DRUGB -0.435 0.490
## EVENTW_12:D 0.300 -0.688 -0.686
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: PNAMP ~ DRUG + EVENT + DRUG * EVENT + diag_dx___1 + (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: 546.3
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -3.0384 -0.4657 -0.1156 0.3706 4.2261
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 8.321 2.885
## Residual 5.230 2.287
## Number of obs: 111, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 4.9863 0.8837 40.0184 5.642 1.5e-06 ***
## DRUGB -0.6265 0.6124 79.3103 -1.023 0.309
## EVENTWeek_12 0.1603 0.6006 78.4636 0.267 0.790
## diag_dx___1PMS -1.5988 1.1429 28.3945 -1.399 0.173
## DRUGB:EVENTWeek_12 0.9427 0.8734 78.7197 1.079 0.284
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) DRUGB EVENTW d____1
## DRUGB -0.322
## EVENTWek_12 -0.340 0.490
## dg_d___1PMS -0.641 -0.024 0.000
## DRUGB:EVENT 0.231 -0.686 -0.688 0.003
##SAND Results
| Baseline |
A |
36.58621 |
10.601608 |
29 |
| Week_12 |
A |
36.25926 |
9.448616 |
29 |
| Baseline |
B |
35.81481 |
11.662026 |
30 |
| Week_12 |
B |
32.10714 |
11.548094 |
29 |
| Baseline |
A |
3.379310 |
4.091924 |
29 |
| Week_12 |
A |
2.740741 |
3.181589 |
29 |
| Baseline |
B |
3.555556 |
3.734798 |
30 |
| Week_12 |
B |
2.517241 |
3.019232 |
29 |
| Baseline |
A |
16.31034 |
8.237993 |
29 |
| Week_12 |
A |
15.62963 |
6.575877 |
29 |
| Baseline |
B |
15.11111 |
7.078316 |
30 |
| Week_12 |
B |
13.03571 |
7.676236 |
29 |
| Baseline |
A |
16.89655 |
5.690499 |
29 |
| Week_12 |
A |
17.88889 |
6.027714 |
29 |
| Baseline |
B |
17.14815 |
7.193500 |
30 |
| Week_12 |
B |
16.53571 |
6.221124 |
29 |

##CGI Improvement next up
| Baseline |
A |
0.0000000 |
0.0000000 |
29 |
| Week_4 |
A |
0.7241379 |
0.7971625 |
29 |
| Week_8 |
A |
0.6206897 |
0.9788402 |
29 |
| Week_12 |
A |
0.8620690 |
0.9533452 |
29 |
| Baseline |
B |
0.0000000 |
0.0000000 |
30 |
| Week_4 |
B |
0.5172414 |
0.9863602 |
29 |
| Week_8 |
B |
1.0357143 |
0.9993384 |
29 |
| Week_12 |
B |
1.3333333 |
0.8770580 |
29 |


## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: cgii_statistics ~ EVENT + DRUG + DRUG * EVENT + GROUP * DRUG +
## (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: 230.6
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -4.8725 -0.2488 0.0250 0.2493 1.8758
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 0.03551 0.1884
## Residual 0.37800 0.6148
## Number of obs: 115, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 0.06897 0.14658 96.63274 0.471 0.6391
## EVENTWeek_12 0.86207 0.16146 82.57645 5.339 8.05e-07 ***
## DRUGB -0.11559 0.19590 82.88805 -0.590 0.5568
## GROUPB -0.14314 0.17604 69.56975 -0.813 0.4189
## EVENTWeek_12:DRUGB 0.46964 0.22975 83.58663 2.044 0.0441 *
## DRUGB:GROUPB 0.23639 0.22967 83.57470 1.029 0.3063
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB GROUPB EVENTW_12:
## EVENTWek_12 -0.551
## DRUGB -0.666 0.412
## GROUPB -0.580 0.000 0.364
## EVENTW_12:D 0.387 -0.703 -0.564 0.002
## DRUGB:GROUP 0.374 0.000 -0.575 -0.648 -0.011
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: cgii_statistics ~ EVENT + DRUG + DRUG * EVENT + (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: 228.4
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -4.9990 -0.1818 0.0198 0.2214 1.7695
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 0.03116 0.1765
## Residual 0.37811 0.6149
## Number of obs: 115, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) -1.905e-16 1.188e-01 1.093e+02 0.000 1.000
## EVENTWeek_12 8.621e-01 1.615e-01 8.361e+01 5.338 7.9e-07 ***
## DRUGB 4.146e-17 1.602e-01 8.440e+01 0.000 1.000
## EVENTWeek_12:DRUGB 4.719e-01 2.297e-01 8.463e+01 2.054 0.043 *
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB
## EVENTWek_12 -0.680
## DRUGB -0.687 0.504
## EVENTW_12:D 0.479 -0.703 -0.697
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: cgii_statistics ~ EVENT + DRUG + DRUG * EVENT + (1 | record_id)
## Data: gh
##
## REML criterion at convergence: 545.8
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -4.1772 -0.5033 0.0167 0.5245 2.2461
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 0.1148 0.3389
## Residual 0.5346 0.7311
## Number of obs: 230, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) -0.007877 0.149510 184.862319 -0.053 0.958041
## EVENTWeek_4 0.724138 0.192005 193.379430 3.771 0.000216 ***
## EVENTWeek_8 0.620690 0.192005 193.379430 3.233 0.001442 **
## EVENTWeek_12 0.862069 0.192005 193.379430 4.490 1.22e-05 ***
## DRUGB 0.007877 0.190641 194.475474 0.041 0.967085
## EVENTWeek_4:DRUGB -0.203951 0.270520 193.639546 -0.754 0.451811
## EVENTWeek_8:DRUGB 0.409917 0.271911 194.186760 1.508 0.133298
## EVENTWeek_12:DRUGB 0.466838 0.273319 194.377783 1.708 0.089227 .
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_4 EVENTWk_8 EVENTWk_12 DRUGB EVENTW_4: EVENTW_8:
## EVENTWeek_4 -0.642
## EVENTWeek_8 -0.642 0.500
## EVENTWek_12 -0.642 0.500 0.500
## DRUGB -0.650 0.504 0.504 0.504
## EVENTW_4:DR 0.456 -0.710 -0.355 -0.355 -0.703
## EVENTW_8:DR 0.456 -0.353 -0.706 -0.353 -0.701 0.494
## EVENTW_12:D 0.453 -0.351 -0.351 -0.702 -0.697 0.491 0.490
##no significant carry over ##CGI-I is different from BL to W12 in
drug and placebo *NOT accounting for dropout yet though ##CGI-I not
significantly different when we look at all timepoints
##ABC
ABC Irritability
| Baseline |
A |
10.758621 |
9.660875 |
29 |
| Week_4 |
A |
9.068965 |
8.280489 |
29 |
| Week_8 |
A |
8.821429 |
6.869436 |
29 |
| Week_12 |
A |
8.344828 |
7.162780 |
29 |
| Baseline |
B |
11.100000 |
9.252586 |
30 |
| Week_4 |
B |
8.344828 |
8.844998 |
29 |
| Week_8 |
B |
7.689655 |
7.860859 |
29 |
| Week_12 |
B |
7.793103 |
7.451650 |
29 |
ABC Social Withdrawal
| Baseline |
A |
13.65517 |
8.469592 |
29 |
| Week_4 |
A |
12.37931 |
7.997383 |
29 |
| Week_8 |
A |
11.20690 |
7.902890 |
29 |
| Week_12 |
A |
10.65517 |
7.560593 |
29 |
| Baseline |
B |
14.76667 |
10.125704 |
30 |
| Week_4 |
B |
11.44828 |
8.862385 |
29 |
| Week_8 |
B |
10.20690 |
7.442059 |
29 |
| Week_12 |
B |
10.31034 |
7.714103 |
29 |
ABC Stereotypy
| Baseline |
A |
7.172414 |
5.251319 |
29 |
| Week_4 |
A |
5.551724 |
4.428691 |
29 |
| Week_8 |
A |
5.750000 |
4.282825 |
29 |
| Week_12 |
A |
5.413793 |
5.348680 |
29 |
| Baseline |
B |
6.866667 |
5.354556 |
30 |
| Week_4 |
B |
5.620690 |
4.828589 |
29 |
| Week_8 |
B |
4.793103 |
4.091623 |
29 |
| Week_12 |
B |
5.000000 |
4.590363 |
29 |
ABC Hyperactivity
| Baseline |
A |
23.44828 |
11.296606 |
29 |
| Week_4 |
A |
20.20690 |
10.366082 |
29 |
| Week_8 |
A |
19.06897 |
9.819554 |
29 |
| Week_12 |
A |
18.82759 |
9.914164 |
29 |
| Baseline |
B |
24.70000 |
9.523655 |
30 |
| Week_4 |
B |
18.96552 |
9.469812 |
29 |
| Week_8 |
B |
18.72414 |
9.617308 |
29 |
| Week_12 |
B |
18.68966 |
10.423543 |
29 |
ABC Inappropriate Speech
| Baseline |
A |
3.034483 |
3.877432 |
29 |
| Week_4 |
A |
2.379310 |
3.004922 |
29 |
| Week_8 |
A |
2.448276 |
2.667077 |
29 |
| Week_12 |
A |
2.172414 |
2.633154 |
29 |
| Baseline |
B |
2.733333 |
3.194104 |
30 |
| Week_4 |
B |
2.103448 |
2.743106 |
29 |
| Week_8 |
B |
2.034483 |
2.757882 |
29 |
| Week_12 |
B |
1.931034 |
3.161499 |
29 |
#ABC graphs






##MCDI
MCDI Amended
| Baseline |
A |
75.35714 |
114.7536 |
29 |
| Week_12 |
A |
84.57143 |
121.3335 |
29 |
| Baseline |
B |
93.06667 |
132.6047 |
30 |
| Week_12 |
B |
117.17857 |
154.1099 |
29 |

##RBS-R
RBS-R Stereotyped Behavior
| Baseline |
A |
5.551724 |
4.005231 |
29 |
| Week_4 |
A |
4.310345 |
3.285286 |
29 |
| Week_8 |
A |
3.931034 |
3.283411 |
29 |
| Week_12 |
A |
3.571429 |
3.338092 |
29 |
| Baseline |
B |
4.933333 |
4.456172 |
30 |
| Week_4 |
B |
4.250000 |
3.502645 |
29 |
| Week_8 |
B |
3.896552 |
3.199831 |
29 |
| Week_12 |
B |
3.928571 |
3.547859 |
29 |
RBS-R Self Injury
| Baseline |
A |
2.827586 |
3.742316 |
29 |
| Week_4 |
A |
2.517241 |
3.323302 |
29 |
| Week_8 |
A |
2.068966 |
2.814897 |
29 |
| Week_12 |
A |
2.142857 |
3.051585 |
29 |
| Baseline |
B |
2.733333 |
3.912256 |
30 |
| Week_4 |
B |
1.500000 |
2.603417 |
29 |
| Week_8 |
B |
1.827586 |
3.117565 |
29 |
| Week_12 |
B |
2.000000 |
3.485419 |
29 |
RBS-R Compulsive Behavior
| Baseline |
A |
3.413793 |
3.914417 |
29 |
| Week_4 |
A |
2.827586 |
3.129000 |
29 |
| Week_8 |
A |
1.965517 |
2.556263 |
29 |
| Week_12 |
A |
2.321429 |
3.067797 |
29 |
| Baseline |
B |
2.166667 |
3.484778 |
30 |
| Week_4 |
B |
1.607143 |
1.931019 |
29 |
| Week_8 |
B |
2.448276 |
2.810519 |
29 |
| Week_12 |
B |
2.035714 |
2.714599 |
29 |
RBS-R Ritualistic Behavior
| Baseline |
A |
2.827586 |
3.306584 |
29 |
| Week_4 |
A |
2.206897 |
2.677676 |
29 |
| Week_8 |
A |
2.310345 |
3.263472 |
29 |
| Week_12 |
A |
2.107143 |
2.346617 |
29 |
| Baseline |
B |
2.400000 |
3.558380 |
30 |
| Week_4 |
B |
2.142857 |
2.704102 |
29 |
| Week_8 |
B |
2.241379 |
3.019640 |
29 |
| Week_12 |
B |
2.000000 |
2.638743 |
29 |
RBS-R Sameness Behavior
| Baseline |
A |
5.517241 |
6.127343 |
29 |
| Week_4 |
A |
4.862069 |
4.348433 |
29 |
| Week_8 |
A |
4.862069 |
4.381162 |
29 |
| Week_12 |
A |
4.214286 |
4.314979 |
29 |
| Baseline |
B |
4.933333 |
4.748381 |
30 |
| Week_4 |
B |
4.321429 |
4.861440 |
29 |
| Week_8 |
B |
4.206897 |
4.776275 |
29 |
| Week_12 |
B |
4.142857 |
5.140358 |
29 |
RBS-R Restricted Behavior
| Baseline |
A |
3.689655 |
2.916743 |
29 |
| Week_4 |
A |
3.827586 |
2.928541 |
29 |
| Week_8 |
A |
3.000000 |
2.299068 |
29 |
| Week_12 |
A |
3.285714 |
2.565543 |
29 |
| Baseline |
B |
3.833333 |
2.937080 |
30 |
| Week_4 |
B |
3.535714 |
2.781981 |
29 |
| Week_8 |
B |
3.206897 |
2.304953 |
29 |
| Week_12 |
B |
3.321429 |
2.625425 |
29 |
RBS-R Total Score
| Baseline |
A |
23.82759 |
17.01275 |
29 |
| Week_4 |
A |
20.55172 |
14.77108 |
29 |
| Week_8 |
A |
18.13793 |
13.43430 |
29 |
| Week_12 |
A |
17.64286 |
13.52970 |
29 |
| Baseline |
B |
21.00000 |
17.85188 |
30 |
| Week_4 |
B |
17.35714 |
12.66729 |
29 |
| Week_8 |
B |
17.82759 |
14.27553 |
29 |
| Week_12 |
B |
17.42857 |
14.69550 |
29 |




##ADAMS
ADAMS Manic Score
| Baseline |
A |
8.620690 |
3.363818 |
29 |
| Week_4 |
A |
7.896552 |
3.885365 |
29 |
| Week_8 |
A |
6.965517 |
3.904967 |
29 |
| Week_12 |
A |
7.551724 |
4.330838 |
29 |
| Baseline |
B |
8.433333 |
3.997269 |
30 |
| Week_4 |
B |
7.758621 |
3.621909 |
29 |
| Week_8 |
B |
7.000000 |
3.644957 |
29 |
| Week_12 |
B |
6.827586 |
3.433750 |
29 |
ADAMS Depressed Score
| Baseline |
A |
3.896552 |
3.233141 |
29 |
| Week_4 |
A |
2.344828 |
2.224472 |
29 |
| Week_8 |
A |
2.172414 |
1.712746 |
29 |
| Week_12 |
A |
2.206897 |
2.144417 |
29 |
| Baseline |
B |
3.033333 |
3.408745 |
30 |
| Week_4 |
B |
2.758621 |
3.180916 |
29 |
| Week_8 |
B |
2.482759 |
2.293168 |
29 |
| Week_12 |
B |
2.275862 |
2.281862 |
29 |
ADAMS Avoid Score
| Baseline |
A |
8.620690 |
4.813773 |
29 |
| Week_4 |
A |
7.655172 |
5.293364 |
29 |
| Week_8 |
A |
7.241379 |
5.068496 |
29 |
| Week_12 |
A |
7.413793 |
4.939037 |
29 |
| Baseline |
B |
8.500000 |
5.063391 |
30 |
| Week_4 |
B |
7.344828 |
4.915543 |
29 |
| Week_8 |
B |
6.620690 |
3.839771 |
29 |
| Week_12 |
B |
6.517241 |
4.954224 |
29 |
ADAMS Obsessive Score
| Baseline |
A |
2.827586 |
2.315614 |
29 |
| Week_4 |
A |
2.000000 |
2.104417 |
29 |
| Week_8 |
A |
1.965517 |
1.917639 |
29 |
| Week_12 |
A |
1.896552 |
1.819435 |
29 |
| Baseline |
B |
2.333333 |
2.089932 |
30 |
| Week_4 |
B |
1.931034 |
1.998768 |
29 |
| Week_8 |
B |
2.172414 |
1.909917 |
29 |
| Week_12 |
B |
2.310345 |
2.019608 |
29 |
ADAMS Anxiety Score
| Baseline |
A |
5.344828 |
4.064444 |
29 |
| Week_4 |
A |
4.172414 |
3.882828 |
29 |
| Week_8 |
A |
3.586207 |
3.300619 |
29 |
| Week_12 |
A |
3.586207 |
3.156821 |
29 |
| Baseline |
B |
4.933333 |
4.168298 |
30 |
| Week_4 |
B |
4.103448 |
3.608965 |
29 |
| Week_8 |
B |
3.482759 |
3.135291 |
29 |
| Week_12 |
B |
3.655172 |
3.477231 |
29 |
#graphs

##VAS table and graph
Caregiver VAS Total
| Baseline |
A |
239.1786 |
55.29788 |
29 |
| Week_4 |
A |
217.5000 |
69.73893 |
29 |
| Week_8 |
A |
216.1786 |
63.62393 |
29 |
| Week_12 |
A |
215.7143 |
64.33584 |
29 |
| Baseline |
B |
234.2414 |
53.85672 |
30 |
| Week_4 |
B |
222.5714 |
69.61025 |
29 |
| Week_8 |
B |
212.2500 |
71.24534 |
29 |
| Week_12 |
B |
187.3214 |
88.74852 |
29 |


Caregiver VAS stats 1) look for carryover
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: vas_tot ~ EVENT + DRUG + DRUG * EVENT + GROUP * DRUG + (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: 1178
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -3.3534 -0.5371 0.0603 0.5822 1.7068
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 2531 50.31
## Residual 1875 43.30
## Number of obs: 113, groups: record_id, 29
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 241.62 16.77 44.93 14.408 <2e-16 ***
## EVENTWeek_12 -23.46 11.57 80.34 -2.028 0.0459 *
## DRUGB -24.93 14.16 80.37 -1.761 0.0821 .
## GROUPB -5.16 22.06 36.65 -0.234 0.8164
## EVENTWeek_12:DRUGB -24.51 16.31 80.42 -1.502 0.1370
## DRUGB:GROUPB 39.09 16.43 81.05 2.380 0.0197 *
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB GROUPB EVENTW_12:
## EVENTWek_12 -0.345
## DRUGB -0.423 0.409
## GROUPB -0.670 0.000 0.214
## EVENTW_12:D 0.245 -0.709 -0.563 0.000
## DRUGB:GROUP 0.243 0.000 -0.583 -0.378 -0.011
##Does look like carryover effects here - would need to sort out
before analyzing (either phase 1 only or something more complicated)
##Sensory Profile
Sensory Profile Low Registration
| Baseline |
A |
46.17241 |
9.878074 |
29 |
| Week_4 |
A |
48.65517 |
10.958610 |
29 |
| Week_8 |
A |
50.96552 |
8.837755 |
29 |
| Week_12 |
A |
48.93103 |
11.423444 |
29 |
| Baseline |
B |
48.13333 |
11.527279 |
30 |
| Week_4 |
B |
51.03448 |
12.918654 |
29 |
| Week_8 |
B |
51.24138 |
10.397991 |
29 |
| Week_12 |
B |
51.00000 |
10.053429 |
29 |
Sensory Profile Sensory Seeking
| Baseline |
A |
91.82759 |
13.98486 |
29 |
| Week_4 |
A |
95.37931 |
15.58941 |
29 |
| Week_8 |
A |
96.17241 |
13.58063 |
29 |
| Week_12 |
A |
93.68966 |
16.01585 |
29 |
| Baseline |
B |
93.96667 |
17.94721 |
30 |
| Week_4 |
B |
97.37931 |
15.35395 |
29 |
| Week_8 |
B |
97.10345 |
16.45198 |
29 |
| Week_12 |
B |
97.55172 |
15.97674 |
29 |
Sensory Profile Sensory Sensitivity
| Baseline |
A |
77.72414 |
11.62785 |
29 |
| Week_4 |
A |
80.03448 |
11.59582 |
29 |
| Week_8 |
A |
81.48276 |
10.66912 |
29 |
| Week_12 |
A |
79.41379 |
11.51557 |
29 |
| Baseline |
B |
79.46667 |
12.12218 |
30 |
| Week_4 |
B |
80.03448 |
12.62787 |
29 |
| Week_8 |
B |
80.41379 |
10.27659 |
29 |
| Week_12 |
B |
81.03448 |
11.82456 |
29 |
Sensory Profile Sensory Avoidance
| Baseline |
A |
112.5517 |
16.47202 |
29 |
| Week_4 |
A |
115.1379 |
14.94448 |
29 |
| Week_8 |
A |
115.5862 |
14.64464 |
29 |
| Week_12 |
A |
113.6207 |
16.24899 |
29 |
| Baseline |
B |
113.8333 |
15.02890 |
30 |
| Week_4 |
B |
115.9655 |
16.71715 |
29 |
| Week_8 |
B |
116.1379 |
15.66325 |
29 |
| Week_12 |
B |
118.2414 |
13.91211 |
29 |
Sensory Profile Total
| Baseline |
A |
453.4483 |
53.84341 |
29 |
| Week_4 |
A |
469.1034 |
54.24241 |
29 |
| Week_8 |
A |
474.3793 |
51.28242 |
29 |
| Week_12 |
A |
462.9655 |
59.61153 |
29 |
| Baseline |
B |
463.9000 |
61.19350 |
30 |
| Week_4 |
B |
474.5517 |
64.62838 |
29 |
| Week_8 |
B |
475.4483 |
61.52211 |
29 |
| Week_12 |
B |
478.6552 |
57.29203 |
29 |
##Sensory Profile Graphs



##Clinician VAS
Clinician VAS - Speech
| Baseline |
A |
86.55172 |
14.82658 |
29 |
| Week_4 |
A |
82.41379 |
16.50869 |
29 |
| Week_8 |
A |
79.65517 |
18.46478 |
29 |
| Week_12 |
A |
75.68966 |
19.76307 |
29 |
| Baseline |
B |
84.83333 |
19.80436 |
30 |
| Week_4 |
B |
80.64286 |
21.86866 |
29 |
| Week_8 |
B |
74.75862 |
23.28190 |
29 |
| Week_12 |
B |
70.17241 |
23.62213 |
29 |
Clinician VAS - Think
| Baseline |
A |
81.20690 |
16.18284 |
29 |
| Week_4 |
A |
75.17241 |
15.95097 |
29 |
| Week_8 |
A |
72.41379 |
16.98848 |
29 |
| Week_12 |
A |
66.72414 |
19.83305 |
29 |
| Baseline |
B |
79.50000 |
19.35824 |
30 |
| Week_4 |
B |
75.89286 |
18.71094 |
29 |
| Week_8 |
B |
71.03448 |
19.01030 |
29 |
| Week_12 |
B |
64.65517 |
19.81752 |
29 |
Clinician VAS - Seizure
| Baseline |
A |
7.241379 |
16.88121 |
29 |
| Week_4 |
A |
4.827586 |
14.54566 |
29 |
| Week_8 |
A |
3.103448 |
11.68132 |
29 |
| Week_12 |
A |
3.793103 |
12.07530 |
29 |
| Baseline |
B |
9.000000 |
19.18153 |
30 |
| Week_4 |
B |
8.928571 |
19.69006 |
29 |
| Week_8 |
B |
8.620690 |
19.40621 |
29 |
| Week_12 |
B |
8.620690 |
19.40621 |
29 |
Clinician VAS - Gross Motor
| Baseline |
A |
38.96552 |
22.84964 |
29 |
| Week_4 |
A |
37.24138 |
21.53014 |
29 |
| Week_8 |
A |
36.20690 |
21.02954 |
29 |
| Week_12 |
A |
35.00000 |
24.53132 |
29 |
| Baseline |
B |
38.83333 |
26.08617 |
30 |
| Week_4 |
B |
37.60714 |
23.79595 |
29 |
| Week_8 |
B |
34.13793 |
22.64118 |
29 |
| Week_12 |
B |
32.06897 |
21.52728 |
29 |
Clinician VAS - Restricted Behavior
| Baseline |
A |
71.55172 |
28.31908 |
29 |
| Week_4 |
A |
68.44828 |
29.00442 |
29 |
| Week_8 |
A |
67.24138 |
28.80309 |
29 |
| Week_12 |
A |
67.58621 |
30.66585 |
29 |
| Baseline |
B |
70.33333 |
28.55525 |
30 |
| Week_4 |
B |
68.92857 |
30.04186 |
29 |
| Week_8 |
B |
64.13793 |
30.91084 |
29 |
| Week_12 |
B |
61.20690 |
29.56999 |
29 |
Clinician VAS - Social Communication
| Baseline |
A |
73.10345 |
23.42975 |
29 |
| Week_4 |
A |
70.00000 |
23.52810 |
29 |
| Week_8 |
A |
68.62069 |
24.60025 |
29 |
| Week_12 |
A |
65.75862 |
25.67469 |
29 |
| Baseline |
B |
76.66667 |
23.82889 |
30 |
| Week_4 |
B |
69.82143 |
23.03307 |
29 |
| Week_8 |
B |
65.51724 |
23.88009 |
29 |
| Week_12 |
B |
63.44828 |
23.53202 |
29 |
Clinician VAS - Sensory
| Baseline |
A |
65.24138 |
30.59371 |
29 |
| Week_4 |
A |
66.72414 |
30.33373 |
29 |
| Week_8 |
A |
64.65517 |
30.67488 |
29 |
| Week_12 |
A |
63.79310 |
31.47151 |
29 |
| Baseline |
B |
67.33333 |
31.85997 |
30 |
| Week_4 |
B |
67.32143 |
32.98378 |
29 |
| Week_8 |
B |
62.75862 |
33.58322 |
29 |
| Week_12 |
B |
60.17241 |
32.96326 |
29 |
Clinician VAS - Daily Activites
| Baseline |
A |
71.58621 |
28.14696 |
29 |
| Week_4 |
A |
68.48276 |
28.46630 |
29 |
| Week_8 |
A |
66.72414 |
28.79347 |
29 |
| Week_12 |
A |
63.62069 |
28.65735 |
29 |
| Baseline |
B |
69.93333 |
27.60177 |
30 |
| Week_4 |
B |
65.00000 |
29.81424 |
29 |
| Week_8 |
B |
63.62069 |
30.49873 |
29 |
| Week_12 |
B |
59.48276 |
30.97651 |
29 |
Clinician VAS - Sleep
| Baseline |
A |
35.17241 |
30.13312 |
29 |
| Week_4 |
A |
31.03448 |
30.13005 |
29 |
| Week_8 |
A |
33.10345 |
31.03609 |
29 |
| Week_12 |
A |
30.86207 |
29.12623 |
29 |
| Baseline |
B |
30.33333 |
28.61557 |
30 |
| Week_4 |
B |
31.96429 |
25.54369 |
29 |
| Week_8 |
B |
28.44828 |
25.46368 |
29 |
| Week_12 |
B |
26.37931 |
24.60025 |
29 |
#Clinician VAS Graphs





#Clinician VAS social communication stats
vassoci <- lmer (clin_vas_6_soc_comm_severe_pms ~ EVENT + DRUG + DRUG*EVENT + (1|record_id), data = ghin_person)
summary(vassoci)
## Linear mixed model fit by REML. t-tests use Satterthwaite's method [
## lmerModLmerTest]
## Formula: clin_vas_6_soc_comm_severe_pms ~ EVENT + DRUG + DRUG * EVENT +
## (1 | record_id)
## Data: ghin_person
##
## REML criterion at convergence: 932
##
## Scaled residuals:
## Min 1Q Median 3Q Max
## -2.29200 -0.55426 0.01607 0.54275 2.32985
##
## Random effects:
## Groups Name Variance Std.Dev.
## record_id (Intercept) 486.85 22.065
## Residual 89.83 9.478
## Number of obs: 117, groups: record_id, 30
##
## Fixed effects:
## Estimate Std. Error df t value Pr(>|t|)
## (Intercept) 73.405 4.401 37.424 16.677 <2e-16 ***
## EVENTWeek_12 -7.345 2.489 84.063 -2.951 0.0041 **
## DRUGB 3.262 2.478 84.178 1.317 0.1916
## EVENTWeek_12:DRUGB -5.074 3.510 84.090 -1.446 0.1520
## ---
## Signif. codes: 0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1
##
## Correlation of Fixed Effects:
## (Intr) EVENTWk_12 DRUGB
## EVENTWek_12 -0.283
## DRUGB -0.288 0.502
## EVENTW_12:D 0.200 -0.709 -0.700